5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results of T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation (AlloHSCT) from HLA matched (HLA-M) or partially mismatched (HLA-MM) unrelated donors (URD) in patients with hematologic malignancies: Sustained engraftment and low incidence of graft-vs-host disease (GvHD)
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Kernan, N. A.; Boulad, F.; Castro-Malaspina, H. R.; Collins, N. H.; Hsu, K.; Perales, M. A.; Small, T. N.; Van Den Brink, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Relevance of 1p and 19q for patients with who grade II/III gliomas
    Meeting Abstract

    Iwamoto, F. M.; Nicolardi, L.; Demopoulos, A.; Barbashina, V.; Ladanyi, M.; Deangelis, L. M.; Hormigo, A.
    Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • EGFR in malignant mesothelioma of the pleura: Analysis of protein expression, gene copy number, and transcript levels
    Meeting Abstract

    Illei, P. B.; Lopez-Rios, F.; Rusch, V.; Ladanyi, M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • EGFR in malignant mesothelioma of the pleura: Analysis of protein expression, gene copy number, and transcript levels
    Meeting Abstract

    Illei, P.; Lopez-Rios, F.; Rusch, V.; Ladanyi, M.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Lack of predictive value of KIR-HLA genotypes for autologous transplant outcome for multiple myeloma
    Meeting Abstract

    Hsu, K. C.; Tricot, G.; Haessler, J.; Pinto-Agnello, C.; Van Rhee, F.; Fox, M.; Dupont, B.
    Blood (2006)

    Fulltext@MSK | Save
  • A comparative study of EGFR mutation screening methods in non-small-cell lung carcinoma
    Meeting Abstract

    Gombos, Z.; Sadowl, C.; Puttaswamy, K.; Brose, M.; Evans, T.; Ladanyi, M.; Van Deerlin, V.
    Journal of Molecular Diagnostics (2006)

    Fulltext@MSK | Save
  • SOX2 antibody responses in patients with various tumor types and SCLC with and without paraneoplastic neurologic syndromes
    Meeting Abstract

    Chen, L.; Narayanan, S.; Posner, J.; Ozbek, U.; Ritter, E.; Gnjatic, S.; Chen, Y.; Old, L.; Gure, A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Overexpression of the MET receptor tyrosine kinase in tumors with TFE3 gene fusions
    Meeting Abstract

    Argani, P.; Tsuda, M.; Chen, M. S.; Edgar, M.; Ladanyi, M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • Overexpression of the MET receptor tyrosine kinase in tumors with TFE3 gene fusions
    Meeting Abstract

    Argani, P.; Tsuda, M.; Chen, M. S.; Edgar, M.; Ladanyi, M.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save